The global market for in-vitro colorectal cancer screening tests is expected to reach USD 840.5 million by 2022, according to a new study by Grand View Research, Inc. Increasing incidences of colorectal cancer and the development of novel CRC screening tests employing methods of genetic screening are some primary factors expected to drive market growth over the forecast period. The implementation of government regulations introducing compulsory application of cancer screening tests, introduction of minimally invasive tests which screen for CRC using DNA and genomic biomarkers, and the presence of high unmet needs are expected to fuel the growth of the in-vitro colorectal cancer screening tests market over the forecast period.
http://www.grandviewresearch.com/industry-analysis/in-vitro-colorectal-cancer-screening-tests-market
No comments:
Post a Comment